This company has not started trading yet. The live 5-factor QL signal switches on automatically on its first session.
Oura is an always-on health intelligence platform designed to transform how people understand and manage their health in everyday life. Oura was built to give the body a voice—translating physiological signals across sleep, activity, readiness, stress, heart health, metabolic health, and women's health into more than 50 metrics and predictive insights.
From Oura Inc.'s Form S-1 filed with the SEC on 2026-09-03. The issuer's own words — QuantLogix does not paraphrase it.
The audited financial statements for this issuer are in its Form S-1 filed 2026-09-03. QuantLogix only publishes figures it can read directly from the filing.
From Oura Inc.'s Form S-1 filed with the SEC on 2026-09-03. Extraction is deterministic — the same filing always produces the same score; 623k characters of the document were scanned. Technology signals are lexical indicators, not a technical audit. Not investment advice; the debut itself will be this score's first grade.
Deal terms come from the public IPO calendar and change up to pricing — an expected date reads “to be announced” until the underwriters set it, and a range is not a final price. Implied market cap and float are arithmetic on those disclosed terms. Nothing on this page is a forecast or a recommendation.